Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Density | 7 | 2021 | 3534 | 0.870 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2015 | 599 | 0.710 |
Why?
|
| Nutritional Status | 2 | 2019 | 1607 | 0.700 |
Why?
|
| Nutritional Support | 1 | 2019 | 172 | 0.590 |
Why?
|
| Speech Disorders | 1 | 2018 | 180 | 0.570 |
Why?
|
| Bone and Bones | 2 | 2017 | 2560 | 0.530 |
Why?
|
| Constipation | 1 | 2018 | 561 | 0.440 |
Why?
|
| Puberty | 1 | 2013 | 498 | 0.340 |
Why?
|
| Absorptiometry, Photon | 4 | 2018 | 1736 | 0.280 |
Why?
|
| Autistic Disorder | 3 | 2023 | 1214 | 0.260 |
Why?
|
| Anxiety | 1 | 2018 | 4538 | 0.220 |
Why?
|
| Smad4 Protein | 1 | 2024 | 191 | 0.210 |
Why?
|
| Child | 20 | 2024 | 79799 | 0.210 |
Why?
|
| Fractures, Bone | 1 | 2015 | 2041 | 0.210 |
Why?
|
| Muscles | 2 | 1998 | 1581 | 0.180 |
Why?
|
| Chromosome Disorders | 1 | 2023 | 499 | 0.180 |
Why?
|
| Myasthenic Syndromes, Congenital | 1 | 2020 | 17 | 0.180 |
Why?
|
| Growth Disorders | 2 | 2024 | 653 | 0.170 |
Why?
|
| Prednisolone | 1 | 2020 | 327 | 0.160 |
Why?
|
| Phenotype | 6 | 2024 | 16548 | 0.160 |
Why?
|
| Adolescent | 15 | 2024 | 87809 | 0.160 |
Why?
|
| Craniofacial Abnormalities | 1 | 2021 | 315 | 0.160 |
Why?
|
| Pica | 1 | 2018 | 37 | 0.150 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2021 | 491 | 0.150 |
Why?
|
| Ion Channel Gating | 1 | 2020 | 436 | 0.150 |
Why?
|
| Muscular Dystrophies | 2 | 2011 | 389 | 0.150 |
Why?
|
| Radius | 2 | 2021 | 440 | 0.150 |
Why?
|
| Muscle Hypotonia | 1 | 2018 | 160 | 0.140 |
Why?
|
| Dystonia | 1 | 2020 | 364 | 0.140 |
Why?
|
| Receptors, Nicotinic | 1 | 2020 | 494 | 0.140 |
Why?
|
| Adenosine Triphosphatases | 1 | 2021 | 833 | 0.140 |
Why?
|
| Diet, Gluten-Free | 1 | 2019 | 280 | 0.140 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2018 | 306 | 0.140 |
Why?
|
| Specialization | 2 | 2018 | 778 | 0.130 |
Why?
|
| Eczema | 1 | 2018 | 245 | 0.130 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2017 | 389 | 0.120 |
Why?
|
| Exercise | 3 | 2017 | 5787 | 0.120 |
Why?
|
| Diet Surveys | 1 | 2018 | 1161 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2021 | 1415 | 0.110 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2015 | 258 | 0.110 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 1504 | 0.110 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2018 | 3701 | 0.110 |
Why?
|
| Age Determination by Skeleton | 1 | 2013 | 126 | 0.110 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 685 | 0.100 |
Why?
|
| Walking | 1 | 2019 | 1190 | 0.100 |
Why?
|
| Vitamin D | 2 | 2018 | 3291 | 0.100 |
Why?
|
| Humans | 34 | 2024 | 760613 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2021 | 22052 | 0.100 |
Why?
|
| Fasting | 1 | 2018 | 1603 | 0.100 |
Why?
|
| Tibia | 1 | 2017 | 1065 | 0.090 |
Why?
|
| Vitamins | 1 | 2019 | 1634 | 0.090 |
Why?
|
| Male | 22 | 2024 | 359718 | 0.090 |
Why?
|
| Language | 1 | 2020 | 1533 | 0.090 |
Why?
|
| Patient Care Planning | 1 | 2016 | 908 | 0.090 |
Why?
|
| Epilepsy | 2 | 2018 | 3267 | 0.090 |
Why?
|
| Social Adjustment | 1 | 2012 | 632 | 0.090 |
Why?
|
| Reference Values | 2 | 2016 | 4925 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 1998 | 1601 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 1399 | 0.080 |
Why?
|
| Workplace | 1 | 2015 | 858 | 0.080 |
Why?
|
| Employment | 1 | 2015 | 1112 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3759 | 0.070 |
Why?
|
| Intelligence | 1 | 2012 | 919 | 0.070 |
Why?
|
| Chromosome Deletion | 2 | 2023 | 1387 | 0.070 |
Why?
|
| Mutation | 5 | 2024 | 29957 | 0.070 |
Why?
|
| Comorbidity | 2 | 2019 | 10553 | 0.070 |
Why?
|
| Parents | 5 | 2020 | 3549 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2021 | 4372 | 0.070 |
Why?
|
| Hospitalization | 2 | 2017 | 10789 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2011 | 1493 | 0.070 |
Why?
|
| Child, Preschool | 6 | 2024 | 42056 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3392 | 0.070 |
Why?
|
| Calcium | 1 | 2018 | 5725 | 0.060 |
Why?
|
| Family | 1 | 2015 | 3189 | 0.060 |
Why?
|
| Facies | 1 | 2024 | 223 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 25941 | 0.050 |
Why?
|
| Clubfoot | 1 | 2024 | 87 | 0.050 |
Why?
|
| Cryptorchidism | 1 | 2024 | 151 | 0.050 |
Why?
|
| Brain | 3 | 2020 | 26951 | 0.050 |
Why?
|
| Hand Deformities, Congenital | 1 | 2024 | 174 | 0.050 |
Why?
|
| Pediatrics | 1 | 2018 | 3586 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2015 | 9716 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2023 | 346 | 0.050 |
Why?
|
| Infant | 3 | 2024 | 36053 | 0.050 |
Why?
|
| Female | 15 | 2024 | 391246 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2018 | 4647 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2017 | 3426 | 0.050 |
Why?
|
| Prevalence | 1 | 2018 | 15686 | 0.050 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 1 | 2020 | 17 | 0.050 |
Why?
|
| Diet | 1 | 2018 | 8010 | 0.040 |
Why?
|
| Hospitals, General | 1 | 2024 | 795 | 0.040 |
Why?
|
| DNA Mutational Analysis | 3 | 2020 | 4108 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2020 | 315 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2016 | 12914 | 0.040 |
Why?
|
| Femur Neck | 1 | 2021 | 311 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2024 | 854 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 643 | 0.040 |
Why?
|
| Myotonia Congenita | 1 | 1998 | 16 | 0.040 |
Why?
|
| Massachusetts | 2 | 2024 | 8803 | 0.040 |
Why?
|
| Myotonic Dystrophy | 1 | 1998 | 78 | 0.040 |
Why?
|
| Dystrophin | 1 | 1998 | 284 | 0.040 |
Why?
|
| Chloride Channels | 1 | 1998 | 221 | 0.030 |
Why?
|
| North America | 1 | 2020 | 1284 | 0.030 |
Why?
|
| United States | 3 | 2020 | 72448 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1998 | 777 | 0.030 |
Why?
|
| Sleep | 2 | 2023 | 4750 | 0.030 |
Why?
|
| Telecommunications | 1 | 2015 | 80 | 0.030 |
Why?
|
| Personnel Turnover | 1 | 2015 | 86 | 0.030 |
Why?
|
| Fractures, Spontaneous | 1 | 2016 | 231 | 0.030 |
Why?
|
| Adult | 6 | 2024 | 220007 | 0.030 |
Why?
|
| Canada | 1 | 2020 | 2126 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2024 | 2567 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 3280 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2016 | 8556 | 0.030 |
Why?
|
| Immune System | 1 | 2019 | 798 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 1690 | 0.030 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 5325 | 0.030 |
Why?
|
| Office Visits | 1 | 2017 | 597 | 0.030 |
Why?
|
| Heat Exhaustion | 1 | 1992 | 13 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2024 | 2982 | 0.030 |
Why?
|
| Injections, Intra-Arterial | 1 | 1992 | 182 | 0.030 |
Why?
|
| Desipramine | 1 | 1992 | 182 | 0.030 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 1992 | 74 | 0.030 |
Why?
|
| Inpatients | 1 | 2023 | 2580 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 1992 | 575 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2021 | 1868 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2015 | 539 | 0.020 |
Why?
|
| Schools | 1 | 2020 | 1480 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1992 | 553 | 0.020 |
Why?
|
| Collagen Type VI | 1 | 2011 | 25 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 1992 | 1154 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1998 | 1334 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2011 | 228 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2023 | 4408 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 210 | 0.020 |
Why?
|
| Genotype | 1 | 2024 | 12957 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2011 | 18955 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 329 | 0.020 |
Why?
|
| Tissue Donors | 1 | 1998 | 2314 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2018 | 2963 | 0.020 |
Why?
|
| Biological Transport | 1 | 1992 | 2086 | 0.020 |
Why?
|
| Overweight | 1 | 2019 | 2421 | 0.020 |
Why?
|
| Young Adult | 3 | 2024 | 58748 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2754 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2016 | 2029 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5201 | 0.020 |
Why?
|
| Hydroxydopamines | 1 | 1986 | 59 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 74333 | 0.020 |
Why?
|
| Linear Models | 1 | 2016 | 5877 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1986 | 174 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 4167 | 0.020 |
Why?
|
| Receptors, Dopamine | 1 | 1986 | 292 | 0.020 |
Why?
|
| Health Personnel | 1 | 2018 | 3310 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 1986 | 191 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 1986 | 248 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1998 | 12427 | 0.010 |
Why?
|
| Registries | 1 | 2020 | 8458 | 0.010 |
Why?
|
| Heterozygote | 1 | 2011 | 2798 | 0.010 |
Why?
|
| Rats | 4 | 1998 | 23709 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2018 | 3835 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2011 | 2668 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1998 | 14661 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2647 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 6015 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2011 | 4626 | 0.010 |
Why?
|
| Epinephrine | 1 | 1986 | 791 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 7805 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 4899 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 26179 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1998 | 20080 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 4716 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 1992 | 3726 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 1986 | 1233 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10755 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17790 | 0.010 |
Why?
|
| Cell Line | 1 | 1992 | 15620 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41337 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 1986 | 850 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1998 | 1060 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1998 | 652 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 2558 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2016 | 80345 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1998 | 1737 | 0.010 |
Why?
|
| Family Health | 1 | 1998 | 1257 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1998 | 2671 | 0.010 |
Why?
|
| Point Mutation | 1 | 1998 | 1594 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1992 | 412 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 15790 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1992 | 415 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1992 | 691 | 0.010 |
Why?
|
| Pedigree | 1 | 1998 | 4578 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1998 | 1817 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1992 | 607 | 0.010 |
Why?
|
| Animals | 4 | 1998 | 167960 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1998 | 4286 | 0.000 |
Why?
|
| Creatinine | 1 | 1992 | 1904 | 0.000 |
Why?
|
| Aged | 1 | 2019 | 169143 | 0.000 |
Why?
|
| Receptors, Neurotensin | 1 | 1986 | 16 | 0.000 |
Why?
|
| Rats, Inbred WKY | 1 | 1986 | 151 | 0.000 |
Why?
|
| Oxidopamine | 1 | 1986 | 172 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1986 | 2094 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1998 | 11070 | 0.000 |
Why?
|
| DNA | 1 | 1998 | 7233 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1998 | 6569 | 0.000 |
Why?
|
| Synaptic Transmission | 1 | 1986 | 1171 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1992 | 12968 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1992 | 6189 | 0.000 |
Why?
|
Concepts
(207)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(64)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_